Genethon and Ampersand Biomedicines announce partnership to design novel AAV vectors with enhanced tissue specificity for more effective and better tolerated gene therapies
PRNewsWire
·
2026-05-21
·
via The Tech Buzz - Press Releases
ÉVRY, France and BOSTON, May 21, 2026 /PRNewswire/ -- Genethon, the French pioneer in the discovery and devel…
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。